Ha U Dong Chun

Jilgyungyi, formerly known as Haudongchun, is a South Korean biotechnology and healthcare company specializing in feminine hygiene and vaginal health. The company is widely recognized for its flagship brand, Jilgyungyi, which offers a range of patented vaginal cleansers and feminine care products designed to maintain optimal pH balance and support a healthy vaginal microbiome. Beyond consumer healthcare, the company operates a research and development division focused on pharmaceutical treatments for gynecological conditions. Its lead drug candidate, HUDC-01, is a treatment for vaginitis that has progressed through Phase 2 clinical trials in South Korea. Jilgyungyi's products are distributed globally, targeting markets in Asia, North America, and Europe. The company is listed on the KONEX stock exchange and continues to innovate in the femtech space through its dedicated R&D center and GMP-certified manufacturing facilities.